How Regeneron, maker of a best-selling eye drug, is using patent tactics to try to thwart competition Battle against Amgen is being closely watched by the biosimilar industry, lawmakers

https://www.statnews.com/pharmalot/2025/07/10/regeneron-amgen-eylea-eyes-patents-lawsuits-biosimilars-legislation/